Skip to main content
Kindstar Globalgene Technology, Inc. logo

Kindstar Globalgene Technology, Inc. — Investor Relations & Filings

Ticker · 9960 ISIN · KYG5262E1044 HKEX Human health and social work activities
Open in API
Filings indexed 602 across all filing types
Latest filing 2023-11-01 Transaction in Own Shar…
Country HK Hong Kong
Listing HKEX 9960

About Kindstar Globalgene Technology, Inc.

http://www.kindstar.com.cn

Kindstar Globalgene Technology, Inc. is a leading independent provider of advanced specialty clinical testing services, specializing in esoteric testing. The company maintains the largest esoteric testing portfolio in its market, utilizing internationally-advanced laboratory facilities for clinical testing, scientific research, and applied R&D. Its comprehensive testing menu, featuring over 100 items, covers critical diagnostic areas including hematology, genetic diseases, gynecology, infectious diseases, neurology, and oncology. These services provide physicians and patients access to specialized diagnostics crucial for the diagnosis and treatment of major diseases.

Recent filings

Filing Released Lang Actions
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and pertains to changes in issued share capital and share buybacks by Kindstar Globalgene Technology, Inc. It contains detailed tables of repurchase of shares with dates and quantities, and confirmations related to share issues and repurchases. The document references rules from the Stock Exchange of Hong Kong (SEHK) and is a regulatory disclosure about share capital changes and repurchases. It is not a full financial report, earnings release, or management discussion, but a formal disclosure of share repurchase transactions. This matches the description of 'Transaction in Own Shares' filings, which report the company's buyback or sale of its own shares. The document length is substantial and contains detailed data, not just an announcement or certification, so it is not RPA or RNS. Therefore, the correct classification is POS (Transaction in Own Shares).
2023-11-01 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2023
Capital/Financing Update Classification · 95% confidence The document is a detailed monthly return report on movements in securities for Kindstar Globalgene Technology, Inc., submitted to the Hong Kong Exchanges and Clearing Limited. It includes information on authorized and issued shares, share options, repurchases, and confirmations related to securities issued during the month ended 31 October 2023. The content focuses on share capital changes and share repurchase details rather than financial performance, earnings, or management commentary. It is a regulatory compliance filing related to share capital movements and confirmations, typical of a capital or financing update. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length (9147 characters) and detailed data support it being a substantive report rather than a brief announcement or certification.
2023-11-01 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Kindstar Globalgene Technology, Inc. It contains detailed data on repurchases of shares over multiple dates, confirming compliance with listing rules of the Stock Exchange of Hong Kong. The content is a regulatory disclosure about share repurchases, not a financial report or earnings release. It is a formal notification of transactions in own shares (share buybacks) as required by exchange rules. Therefore, the document fits the category of 'Transaction in Own Shares' (POS). The document length and detail confirm it is the report itself, not just an announcement or certification.
2023-10-31 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and pertains to changes in issued share capital and share buybacks by Kindstar Globalgene Technology, Inc. It details numerous repurchases of shares with dates and quantities, confirming compliance with listing rules of the Stock Exchange of Hong Kong. The content is focused on reporting share repurchase transactions and changes in share capital, not on financial results, management changes, or other report types. This matches the definition of a 'Transaction in Own Shares' filing, which reports company buybacks or sales of its own shares. The document length is substantial and contains detailed transactional data, not merely an announcement or certification. Therefore, the appropriate classification is POS (Transaction in Own Shares).
2023-10-30 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks for Kindstar Globalgene Technology, Inc. It contains detailed tables of repurchase of shares with dates and quantities, confirming compliance with listing rules of the Stock Exchange of Hong Kong. The content focuses on reporting share repurchases and changes in issued shares, which aligns with announcements regarding share repurchase activities. It is not a full financial report, earnings release, or management discussion, but a regulatory disclosure of share capital changes and buybacks. Therefore, the document fits best under the category of 'Transaction in Own Shares' (POS). The document length is substantial and contains detailed data, confirming it is the report itself, not just an announcement of a report.
2023-10-27 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 95% confidence The document is titled 'Next Day Disclosure Return' and pertains to changes in issued share capital and share buybacks by Kindstar Globalgene Technology, Inc. It details numerous repurchases of shares with dates and quantities, confirming compliance with listing rules of the Stock Exchange of Hong Kong. The content is focused on reporting share repurchase transactions and changes in share capital, which aligns with the category for reporting company transactions in its own shares. The document is not an annual report, earnings release, or management discussion, nor is it a proxy or voting result announcement. It is a detailed disclosure of share repurchase activity, fitting the 'Transaction in Own Shares' category.
2023-10-26 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.